Back to: products

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial)

PrintEmail
Dec 2022 - 166Pages - From $3,600
(Excel Data Sheet: $2,000)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures. 
Highlighted with 83 tables and 84 figures, this 166-page report “Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global small molecule contract development and manufacturing organization (CDMO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
 
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure 
• Growth Drivers 
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule contract development and manufacturing organization (CDMO) market in every aspect of the classification from perspectives of Product Type, Service Type, Customer Type, Therapeutic Area, and Region. 
 
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Active Pharmaceutical Ingredients (API) 
o Branded Drugs
o Generic Drugs
• Finished Dosage Formulations (FDF)
o Oral Solid Drugs
o Injectable Drugs
o Semi-solid or Liquid Drugs
o Other FDFs
 
Based on Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Preclinical Use
• Clinical Use
o Phase I
o Phase II
o Phase III
o Phase IV
• Commercial Use
 
By Customer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Pharmaceutical Firms
• Biotechnology Firms
 
By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 
• Infectious Diseases
• Oncology
• Ophthalmology 
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas
 
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Service Type and Therapeutic Area over the forecast years are also included.
 
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players: 
Boehringer Ingelheim
Cambrex Corporation
Catalent
Cipla
Covance Inc.
Lonza Group Ltd.
Medley Pharmaceuticals
NatcoPharma
Patheon (Thermo Fisher Scientific, Inc.)
Piramal Pharma Solutions
RedHillBiopharma
Siegfried Holding AG
STA Pharmaceutical
Sun Pharmaceutical
Teva 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
 
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Global Market by Product Type 41
3.1 Market Overview by Product Type 41
3.2 Active Pharmaceutical Ingredients (API) 43
3.2.1 Branded Drugs 44
3.2.2 Generic Drugs 45
3.3 Finished Dosage Formulations (FDF) 46
3.3.1 Oral Solid Drugs 48
3.3.2 Injectable Drugs 49
3.3.3 Semi-solid or Liquid Drugs 50
3.3.4 Other FDFs 51
4 Segmentation of Global Market by Service Type 52
4.1 Market Overview by Service Type 52
4.2 Preclinical Use 54
4.3 Clinical Use 55
4.3.1 Phase I 57
4.3.2 Phase II 58
4.3.3 Phase III 59
4.3.4 Phase IV 60
4.4 Commercial Use 61
5 Segmentation of Global Market by Customer Type 62
5.1 Market Overview by Customer Type 62
5.2 Pharmaceutical Firms 64
5.3 Biotechnology Firms 65
6 Segmentation of Global Market by Therapeutic Area 66
6.1 Market Overview by Therapeutic Area 66
6.2 Infectious Diseases 68
6.3 Oncology 69
6.4 Ophthalmology 70
6.5 Cardiovascular Disorders 71
6.6 Central Nervous System 72
6.7 Respiratory Disorders 73
6.8 Metabolic Diseases 74
6.9 Other Therapeutic Areas 75
7 Segmentation of Global Market by Region 76
7.1 Geographic Market Overview 2021-2031 76
7.2 North America Market 2021-2031 by Country 80
7.2.1 Overview of North America Market 80
7.2.2 U.S. 84
7.2.3 Canada 87
7.2.4 Mexico 89
7.3 European Market 2021-2031 by Country 91
7.3.1 Overview of European Market 91
7.3.2 Germany 95
7.3.3 U.K. 97
7.3.4 France 99
7.3.5 Spain 101
7.3.6 Italy 103
7.3.7 Netherlands 105
7.3.8 Rest of European Market 107
7.4 Asia-Pacific Market 2021-2031 by Country 109
7.4.1 Overview of Asia-Pacific Market 109
7.4.2 Japan 113
7.4.3 China 116
7.4.4 Australia 118
7.4.5 India 120
7.4.6 South Korea 122
7.4.7 Rest of APAC Region 124
7.5 South America Market 2021-2031 by Country 126
7.5.1 Argentina 129
7.5.2 Brazil 131
7.5.3 Chile 133
7.5.4 Rest of South America Market 135
7.6 MEA Market 2021-2031 by Country 136
7.6.1 UAE 139
7.6.2 Saudi Arabia 141
7.6.3 South Africa 143
7.6.4 Other National Markets 145
8 Competitive Landscape 146
8.1 Overview of Key Vendors 146
8.2 New Product Launch, Partnership, Investment, and M&A 149
8.3 Company Profiles 150
Boehringer Ingelheim 150
Cambrex Corporation 152
Catalent 153
Cipla 154
Covance Inc. 155
Lonza Group Ltd. 156
Medley Pharmaceuticals 157
NatcoPharma 158
Patheon (Thermo Fisher Scientific, Inc.) 159
Piramal Pharma Solutions 160
RedHillBiopharma 161
Siegfried Holding AG 162
STA Pharmaceutical 163
Sun Pharmaceutical 164
Teva 165
RELATED REPORTS 166
List of Tables:
 
Table 1.  Snapshot of Global Small Molecule CDMO Market in Balanced Perspective, 2021-2031 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. Worldwide Total Number of Registered Clinical Trials 29
Table 4.  Main Product Trends and Market Opportunities in Global Small Molecule CDMO Market 33
Table 5. Global Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 41
Table 6. Global Small Molecule CDMO Market: API by Type, 2021-2031, $ mn 43
Table 7. Global Small Molecule CDMO Market: FDF by Type, 2021-2031, $ mn 47
Table 8. Global Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 52
Table 9. Global Small Molecule CDMO Market: Clinical Use by Type, 2021-2031, $ mn 56
Table 10. Global Small Molecule CDMO Market by Customer Type, 2021-2031, $ mn 62
Table 11. Global Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 66
Table 12. Global Small Molecule CDMO Market by Region, 2021-2031, $ mn 77
Table 13.  Leading National Small Molecule CDMO Market, 2021 and 2031, $ mn 79
Table 14. North America Small Molecule CDMO Market by Country, 2021-2031, $ mn 82
Table 15. U.S. Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 86
Table 16. U.S. Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 86
Table 17. U.S. Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 86
Table 18. Canada Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 88
Table 19. Canada Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 88
Table 20. Canada Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 88
Table 21. Mexico Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 90
Table 22. Mexico Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 90
Table 23. Mexico Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 90
Table 24. Europe Small Molecule CDMO Market by Country, 2021-2031, $ mn 94
Table 25. Germany Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 96
Table 26. Germany Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 96
Table 27. Germany Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 96
Table 28. U.K. Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 98
Table 29. U.K. Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 98
Table 30. U.K. Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 98
Table 31. France Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 100
Table 32. France Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 100
Table 33. France Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 100
Table 34. Spain Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 102
Table 35. Spain Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 102
Table 36. Spain Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 102
Table 37. Italy Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 104
Table 38. Italy Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 104
Table 39. Italy Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 104
Table 40. Netherlands Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 106
Table 41. Netherlands Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 106
Table 42. Netherlands Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 106
Table 43. Small Molecule CDMO Market in Rest of Europe by Country, 2021-2031, $ mn 108
Table 44. APAC Small Molecule CDMO Market by Country, 2021-2031, $ mn 111
Table 45. Japan Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 115
Table 46. Japan Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 115
Table 47. Japan Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 115
Table 48. China Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 117
Table 49. China Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 117
Table 50. China Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 117
Table 51. Australia Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 119
Table 52. Australia Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 119
Table 53. Australia Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 119
Table 54. India Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 121
Table 55. India Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 121
Table 56. India Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 121
Table 57. South Korea Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 123
Table 58. South Korea Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 123
Table 59. South Korea Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 123
Table 60. Small Molecule CDMO Market in Rest of APAC by Country/Region, 2021-2031, $ mn 125
Table 61. South America Small Molecule CDMO Market by Country, 2021-2031, $ mn 128
Table 62. Argentina Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 130
Table 63. Argentina Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 130
Table 64. Argentina Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 130
Table 65. Brazil Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 132
Table 66. Brazil Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 132
Table 67. Brazil Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 132
Table 68. Chile Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 134
Table 69. Chile Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 134
Table 70. Chile Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 134
Table 71. MEA Small Molecule CDMO Market by Country, 2021-2031, $ mn 138
Table 72. UAE Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 140
Table 73. UAE Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 140
Table 74. UAE Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 140
Table 75. Saudi Arabia Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 142
Table 76. Saudi Arabia Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 142
Table 77. Saudi Arabia Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 142
Table 78. South Africa Small Molecule CDMO Market by Product Type, 2021-2031, $ mn 144
Table 79. South Africa Small Molecule CDMO Market by Service Type, 2021-2031, $ mn 144
Table 80. South Africa Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn 144
Table 81. Boehringer Ingelheim: Company Snapshot 150
Table 82. Boehringer Ingelheim: Business Segmentation 151
Table 83. Boehringer Ingelheim: Product Portfolio 151
 
 
 
 
List of Figures:
 
Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 18
Figure 4. Global Small Molecule CDMO Market, 2021-2031, $ mn 21
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Global Small Molecule CDMO Market 26
Figure 7. Primary Restraints and Impact Factors of Global Small Molecule CDMO Market 30
Figure 8. Investment Opportunity Analysis 34
Figure 9. Porter’s Fiver Forces Analysis of Global Small Molecule CDMO Market 37
Figure 10. Breakdown of Global Small Molecule CDMO Market by Product Type, 2021-2031, % of Revenue 42
Figure 11. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 42
Figure 12. Global Small Molecule CDMO Market by Product Type: Active Pharmaceutical Ingredients (API), 2021-2031, $ mn 43
Figure 13. Global Small Molecule CDMO Market by API: Branded Drugs, 2021-2031, $ mn 44
Figure 14. Global Small Molecule CDMO Market by API: Generic Drugs, 2021-2031, $ mn 45
Figure 15. Global Small Molecule CDMO Market by Product Type: Finished Dosage Formulations (FDF), 2021-2031, $ mn 46
Figure 16. Global Small Molecule CDMO Market by FDF: Oral Solid Drugs, 2021-2031, $ mn 48
Figure 17. Global Small Molecule CDMO Market by FDF: Injectable Drugs, 2021-2031, $ mn 49
Figure 18. Global Small Molecule CDMO Market by FDF: Semi-solid or Liquid Drugs, 2021-2031, $ mn 50
Figure 19. Global Small Molecule CDMO Market by FDF: Other FDFs, 2021-2031, $ mn 51
Figure 20. Breakdown of Global Small Molecule CDMO Market by Service Type, 2021-2031, % of Sales Revenue 53
Figure 21. Global Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 53
Figure 22. Global Small Molecule CDMO Market by Service Type: Preclinical Use, 2021-2031, $ mn 54
Figure 23. Global Small Molecule CDMO Market by Service Type: Clinical Use, 2021-2031, $ mn 55
Figure 24. Global Small Molecule CDMO Market by Clinical Use: Phase I, 2021-2031, $ mn 57
Figure 25. Global Small Molecule CDMO Market by Clinical Use: Phase II, 2021-2031, $ mn 58
Figure 26. Global Small Molecule CDMO Market by Clinical Use: Phase III, 2021-2031, $ mn 59
Figure 27. Global Small Molecule CDMO Market by Clinical Use: Phase IV, 2021-2031, $ mn 60
Figure 28. Global Small Molecule CDMO Market by Service Type: Commercial Use, 2021-2031, $ mn 61
Figure 29. Breakdown of Global Small Molecule CDMO Market by Customer Type, 2021-2031, % of Sales Revenue 63
Figure 30. Global Addressable Market Cap in 2022-2031 by Customer Type, Value ($ mn) and Share (%) 63
Figure 31. Global Small Molecule CDMO Market by Customer Type: Pharmaceutical Firms, 2021-2031, $ mn 64
Figure 32. Global Small Molecule CDMO Market by Customer Type: Biotechnology Firms, 2021-2031, $ mn 65
Figure 33. Breakdown of Global Small Molecule CDMO Market by Therapeutic Area, 2021-2031, % of Revenue 67
Figure 34. Global Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%) 67
Figure 35. Global Small Molecule CDMO Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn 68
Figure 36. Global Small Molecule CDMO Market by Therapeutic Area: Oncology, 2021-2031, $ mn 69
Figure 37. Global Small Molecule CDMO Market by Therapeutic Area: Ophthalmology, 2021-2031, $ mn 70
Figure 38. Global Small Molecule CDMO Market by Therapeutic Area: Cardiovascular Disorders, 2021-2031, $ mn 71
Figure 39. Global Small Molecule CDMO Market by Therapeutic Area: Central Nervous System, 2021-2031, $ mn 72
Figure 40. Global Small Molecule CDMO Market by Therapeutic Area: Respiratory Disorders, 2021-2031, $ mn 73
Figure 41. Global Small Molecule CDMO Market by Therapeutic Area: Metabolic Diseases, 2021-2031, $ mn 74
Figure 42. Global Small Molecule CDMO Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn 75
Figure 43.  Global Market Snapshot by Region 76
Figure 44.  Geographic Spread of Worldwide Small Molecule CDMO Market, 2021-2031, % of Sales Revenue 77
Figure 45. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 78
Figure 46.  North American Small Molecule CDMO Market, 2021-2031, $ mn 81
Figure 47. Breakdown of North America Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue 82
Figure 48. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 83
Figure 49. U.S. Small Molecule CDMO Market, 2021-2031, $ mn 85
Figure 50. Canada Small Molecule CDMO Market, 2021-2031, $ mn 87
Figure 51.  Small Molecule CDMO Market in Mexico, 2021-2031, $ mn 89
Figure 52.  European Small Molecule CDMO Market, 2021-2031, $ mn 92
Figure 53. Breakdown of European Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue 93
Figure 54. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 94
Figure 55.  Small Molecule CDMO Market in Germany, 2021-2031, $ mn 95
Figure 56.  Small Molecule CDMO Market in U.K., 2021-2031, $ mn 97
Figure 57.  Small Molecule CDMO Market in France, 2021-2031, $ mn 99
Figure 58.  Small Molecule CDMO Market in Spain, 2021-2031, $ mn 101
Figure 59.  Small Molecule CDMO Market in Italy, 2021-2031, $ mn 103
Figure 60.  Small Molecule CDMO Market in Netherlands, 2021-2031, $ mn 105
Figure 61.  Small Molecule CDMO Market in Rest of Europe, 2021-2031, $ mn 107
Figure 62. Asia-Pacific Small Molecule CDMO Market, 2021-2031, $ mn 110
Figure 63. Breakdown of APAC Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue 110
Figure 64. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 112
Figure 65.  Small Molecule CDMO Market in Japan, 2021-2031, $ mn 114
Figure 66.  Small Molecule CDMO Market in China, 2021-2031, $ mn 116
Figure 67.  Small Molecule CDMO Market in Australia, 2021-2031, $ mn 118
Figure 68.  Small Molecule CDMO Market in India, 2021-2031, $ mn 120
Figure 69.  Small Molecule CDMO Market in South Korea, 2021-2031, $ mn 122
Figure 70.  Small Molecule CDMO Market in Rest of APAC, 2021-2031, $ mn 124
Figure 71. South America Small Molecule CDMO Market, 2021-2031, $ mn 127
Figure 72. Breakdown of South America Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue 127
Figure 73. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 128
Figure 74.  Small Molecule CDMO Market in Argentina, 2021-2031, $ mn 129
Figure 75.  Small Molecule CDMO Market in Brazil, 2021-2031, $ mn 131
Figure 76.  Small Molecule CDMO Market in Chile, 2021-2031, $ mn 133
Figure 77.  Small Molecule CDMO Market in Rest of South America, 2021-2031, $ mn 135
Figure 78. Small Molecule CDMO Market in Middle East and Africa (MEA), 2021-2031, $ mn 137
Figure 79. Breakdown of MEA Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue 137
Figure 80. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 138
Figure 81.  Small Molecule CDMO Market in UAE, 2021-2031, $ mn 139
Figure 82.  Small Molecule CDMO Market in Saudi Arabia, 2021-2031, $ mn 141
Figure 83.  Small Molecule CDMO Market in South Africa, 2021-2031, $ mn 143
Figure 84. Growth Stage of Global Small Molecule CDMO Industry over the Forecast Period 146
 

Reviews

There are yet no reviews for this product.